Items where Author is "Shaygannejad, V."

Article

(2025) Association between diffusion tensor imaging measurements and cognitive performances in people with multiple sclerosis: A systematic review and meta-analysis. Multiple Sclerosis and Related Disorders. p. 13. ISSN 2211-0348

(2025) Clinical and psychological factors associated with fear of relapse in people with multiple sclerosis: A cross-sectional study. Journal of Clinical Neuroscience. p. 8. ISSN 0967-5868

(2025) Frequency of tremor in people with multiple sclerosis: A systematic review and meta-analysis. Clinical parkinsonism & related disorders. p. 100315. ISSN 2590-1125 (Electronic) 2590-1125 (Linking)

(2025) Gustatory dysfunction in multiple sclerosis: a systematic review and meta-analysis. Chemical Senses. p. 10. ISSN 0379-864X

(2025) Investigating the Safety of Fampridine in Patients with Different Stages of Multiple Sclerosis. International Journal of Preventive Medicine. p. 8. ISSN 2008-7802

(2025) Magnetic resonance imaging-based biomarkers of multiple sclerosis and neuromyelitis optica spectrum disorder: a systematic review and meta-analysis. Journal of Neurology. p. 25. ISSN 0340-5354

(2025) Sexual function and related predictors in male with multiple sclerosis and neuromyelitis optica spectrum disorder: a case-control study. The journal of sexual medicine. pp. 274-281. ISSN 1743-6109 (Electronic) 1743-6095 (Linking)

(2025) Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis. JAMA neurology. ISSN 2168-6157 (Electronic) 2168-6149 (Print) 2168-6149 (Linking)

(2025) Timed 25-foot walk test is independently associated with cognitive function in multiple sclerosis: a cross-sectional study. European Journal of Medical Research. p. 299. ISSN 2047-783X (Electronic) 0949-2321 (Print) 0949-2321 (Linking)

(2025) Uveitis among people with multiple sclerosis: A systematic review and meta-analysis. Survey of Ophthalmology. pp. 331-338. ISSN 0039-6257

(2025) The prevalence of cancer in patients with multiple sclerosis (MS) who received rituximab: a systematic review and meta-analysis. Neurologia. pp. 41-47. ISSN 0213-4853

(2025) The prevalence of sexual dysfunction and erectile dysfunction in men with multiple sclerosis: A systematic review and meta-analysis. Neurologia. pp. 22-31. ISSN 0213-4853

(2025) The relationship between optical coherence tomography and magnetic resonance imaging measurements in people with multiple sclerosis: A systematic review and meta-analysis. Journal of the Neurological Sciences. p. 9. ISSN 0022-510X

(2024) Abnormal body mass index is associated with risk of multiple sclerosis: A systematic review and meta-analysis. Obesity Research & Clinical Practice. pp. 311-321. ISSN 1871-403X

(2024) Association Between Body Mass Index (BMI) and Multiple Sclerosis Risk: A Systematic Review and Meta-Analysis. Multiple Sclerosis Journal. pp. 900-901. ISSN 1352-4585

(2024) The Association of Salivary Cortisol Levels With Depression, Anxiety, and Quality of Life in Male Relapsing-Remitting Multiple Sclerosis Patients: A Case-Control Study. Acta Neurologica Scandinavica. p. 11. ISSN 0001-6314

(2024) Asthma and chronic obstructive pulmonary disease (COPD) in people with multiple sclerosis: A systematic review and meta-analysis. Multiple Sclerosis and Related Disorders. p. 11. ISSN 2211-0348

(2024) Bone loss and fracture in people with multiple sclerosis: A systematic review and meta-analysis. Multiple Sclerosis and Related Disorders. p. 11. ISSN 2211-0348

(2024) Cancer and mortality risks among people with multiple sclerosis: A population-based study in Isfahan, Iran. Plos One. p. 16. ISSN 1932-6203

(2024) Cervical Spondylosis Severity and Its Correlation with Clinical Parameters and Cervical Lesions in Multiple Sclerosis: A Cross-Sectional MRI Study. Archives of Neuroscience. p. 7. ISSN 2322-3944

(2024) Cognitive function and brain magnetic resonance imaging profiles in neuromyelitis optica spectrum disorder and multiple sclerosis. Journal of Research in Medical Sciences. p. 7. ISSN 1735-1995

(2024) Comparative Effectiveness of Natalizumab, Fingolimod, and Injectable Therapies in Pediatric-Onset Multiple Sclerosis A Registry-Based Study. Neurology. p. 12. ISSN 0028-3878

(2024) Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom. Journal of Medical Economics. pp. 109-125. ISSN 1369-6998

(2024) Comparative effectiveness of dimethyl fumarate versus non-specific immunosuppressants: Real-world evidence from MSBase. Multiple Sclerosis Journal-Experimental Translational and Clinical. p. 13.

(2024) Comparing the consequences of COVID-19 vaccination between central nervous system (CNS) demyelinating diseases and other neurological disorders. Vaccine. p. 9. ISSN 0264-410X

(2024) Concurrent glioma and multiple sclerosis: A systematic review of case reports. Multiple Sclerosis and Related Disorders. p. 10. ISSN 2211-0348

(2024) Consanguineous marriage among familial multiple sclerosis subjects: A national registry-based study. Heliyon. p. 11.

(2024) Dysphagia in neuromyelitis optica spectrum disorder and multiple sclerosis: A comparison of frequency, severity, and effects on quality of life. Multiple Sclerosis and Related Disorders. p. 7. ISSN 2211-0348

(2024) Early clinical response and complications of therapeutic plasma exchange in central nervous system demyelinating diseases. Journal of Central Nervous System Disease. p. 8. ISSN 1179-5735

(2024) Effectiveness of Schema Therapy on Anxiety, Depression, Fatigue, Quality of Life, and Sleep in Patients with Multiple Sclerosis: A Randomized Controlled Trial. Middle East Journal of Rehabilitation and Health Studies. ISSN 24234451 (ISSN)

(2024) Efficacy and safety of peginterferon beta-1a compared to interferon beta-1a in relapsing remitting multiple sclerosis patients: A phase 3, randomized, non-inferiority clinical trial (PEGINTEGRITY). Multiple Sclerosis and Related Disorders. p. 8. ISSN 2211-0348

(2024) Evaluating efficacy and safety of ocrelizumab biosimilar (Xacrel) compared to the originator (Ocrevus) in relapsing multiple sclerosis: a phase III, randomized, equivalency, clinical trial. Scientific Reports. p. 12. ISSN 2045-2322

(2024) Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies. Journal of Neurology. pp. 472-485. ISSN 1432-1459 (Electronic) 0340-5354 (Print) 0340-5354 (Linking)

(2024) Factors associated with community integration in people with multiple sclerosis with mild and moderate levels of disability: a cross-sectional study. International Journal of Therapy and Rehabilitation. p. 11. ISSN 1741-1645

(2024) Fulminant multiple sclerosis versus autoimmune encephalitis: A case report. Clinical Case Reports. p. 5. ISSN 2050-0904

(2024) How patients with neuromyelitis optica spectrum disorder accumulate disability. Multiple Sclerosis Journal. pp. 1158-1160. ISSN 1352-4585

(2024) Hypertension in Multiple Sclerosis: Prevalence, Risk Determinants, and Disease Associations - A Systematic Review and Meta-analysis. Multiple Sclerosis Journal. pp. 795-796. ISSN 1352-4585

(2024) Insights into the interplay between Epstein-Barr virus (EBV) and multiple sclerosis (MS): A state-of-the-art review and implications for vaccine development. Health Science Reports. p. 12.

(2024) Interdependency of NINJ2 gene expression and polymorphism with susceptibility and response to interferon beta in patients with multiple sclerosis. The International journal of neuroscience. pp. 347-352. ISSN 1563-5279 (Electronic) 0020-7454 (Linking)

(2024) Investigation of the effects of cocoa powder on fatigue severity in patients with relapsing-remitting multiple sclerosis: A randomized controlled trial. Clinical Nutrition Open Science. pp. 136-148. ISSN 26672685 (ISSN)

(2024) Magnetic resonance imaging-based biomarkers of multiple sclerosis and neuromyelitis optica spectrum disorder: a systematic review and meta-analysis. Journal of Neurology. p. 77. ISSN 1432-1459 (Electronic) 0340-5354 (Linking)

(2024) Multiple sclerosis and personality traits: associations with depression and anxiety. European Journal of Medical Research. p. 8. ISSN 0949-2321

(2024) Neuroimaging markers and disability scales in multiple sclerosis: A systematic review and meta-analysis. Plos One. p. 20. ISSN 1932-6203

(2024) Neurological efficacy and safety of mesenchymal stem cells (MSCs) therapy in people with multiple sclerosis (pwMS): An updated systematic review and meta-analysis. Multiple Sclerosis and Related Disorders. p. 16. ISSN 2211-0348

(2024) Onabotulinum toxin A improves neurogenic detrusor overactivity following spinal cord injury: a systematic review and meta-analysis. Spinal Cord. pp. 285-294. ISSN 1362-4393

(2024) Preserving neurological function in patients at high risk and low risk of aggressive MS. Multiple Sclerosis Journal. pp. 631-634. ISSN 1352-4585

(2024) Prevalence and Outcome of COVID-19 Among Parkinson's Disease: A Report from Iran. Archives of Neuroscience. p. 8. ISSN 2322-3944

(2024) Prevalence and incidence of multiple sclerosis in Isfahan, Iran between 1996 and 2021: A population-based study. Multiple Sclerosis and Related Disorders. p. 8. ISSN 2211-0348

(2024) Prevalence of cognitive impairment (CI) in patients with multiple sclerosis (MS): A systematic review and meta-analysis. Caspian Journal of Internal Medicine. pp. 392-413. ISSN 2008-6164 (Print) 2008-6172 (Electronic) 2008-6164 (Linking)

(2024) Protocol of a prospective multicenter study on comorbidity impact on multiple sclerosis and antibody-mediated diseases of the central nervous system (COMMIT). Frontiers in Immunology. p. 14. ISSN 1664-3224

(2024) The Role of Glial Fibrillary Acidic Protein as a Biomarker in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Systematic Review and Meta-Analysis. Medicina-Lithuania. p. 22. ISSN 1010-660X

(2024) Safety and Efficacy of COVID-19 Vaccines Among Patients with Multiple Sclerosis: Letter to Editor. International Journal of Preventive Medicine. p. 2. ISSN 2008-7802

(2024) Sexual function and related predictors in male with multiple sclerosis and neuromyelitis optica spectrum disorder: a case-control study. Journal of Sexual Medicine. pp. 274-281. ISSN 1743-6095

(2024) Validity and reliability of the Persian version of Recce stigma scale in people with multiple sclerosis and its impact on quality of life. Bmc Neurology. p. 9.

(2024) The association between dietary inflammatory index and risk of neuromyelitis optica spectrum disorder: a case-control study. Nutritional Neuroscience. pp. 1450-1457. ISSN 1028-415X

(2024) A national registry-based study of ethnic differences in people with multiple sclerosis in Iran. Clinical Neurology and Neurosurgery. p. 5. ISSN 0303-8467

(2024) The role of parental consanguinity and familial aggregation in development of multiple sclerosis: a case-control study. European Journal of Medical Research. p. 11. ISSN 0949-2321

(2024) A standardised definition of progression independent of relapse activity in multiple sclerosis. Multiple Sclerosis Journal. pp. 442-445. ISSN 1352-4585

(2023) ADAR Expression and Single Nucleotide Variants in Multiple Sclerosis Patients Affect the Response to Interferon Beta Therapy. Global Medical Genetics. pp. 164-171. ISSN 2699-9404 (Electronic) 2699-9404 (Linking)

(2023) Assessment of Retinal Nerve Fiber Layer (RNFL) and Retinal Ganglion Cell Layer (RGCL) Thickness in Radiologically Isolated Syndrome (RIS). Archives of Neuroscience. p. 7. ISSN 2322-3944

(2023) Assessment of intelligence quotient in patients with neuromyelitis optica spectrum disease and multiple sclerosis. Multiple Sclerosis and Related Disorders. p. 104492. ISSN 2211-0356 (Electronic) 2211-0348 (Linking)

(2023) Association Between Helicobacter Pylori Infection and Seronegative Neuromyelitis Optica Spectrum Disorder. Caspian Journal of Neurological Sciences. pp. 9-14. ISSN 23834307 (ISSN)

(2023) CNS demyelinating disease following inactivated or viral vector SARS-CoV-2 vaccines: A case series. Vaccine. pp. 1003-1008. ISSN 1873-2518 (Electronic) 0264-410X (Print) 0264-410X (Linking)

(2023) Comparative effectiveness in multiple sclerosis: A methodological comparison. Multiple Sclerosis Journal. pp. 326-332. ISSN 1352-4585

(2023) Comparing the hippocampal volumetric atrophy between demented and nondemented individuals with Parkinson's disease: A systematic review and meta-analysis. Health Science Reports. p. 11.

(2023) Demographic and Clinical Characteristics of Familial and Sporadic Multiple Sclerosis Patients. International Journal of Preventive Medicine. p. 7. ISSN 2008-7802

(2023) Disability accrual in primary and secondary progressive multiple sclerosis. Journal of Neurology Neurosurgery and Psychiatry. pp. 707-717. ISSN 0022-3050

(2023) Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal. pp. 875-883. ISSN 1352-4585

(2023) Effect of deep gray matter atrophy on information processing speed in early relapsing-remitting multiple sclerosis. Multiple Sclerosis and Related Disorders. p. 6. ISSN 2211-0348

(2023) Effect of high-efficacy therapy on the course of disability in paediatric-onset multiple sclerosis. Multiple Sclerosis Journal. pp. 103-105. ISSN 1352-4585

(2023) Effectiveness of BBIBP-CorV vaccine in preventing SARS-CoV2 infection and severe outcomes in people living with multiple sclerosis: A population-based study. Multiple Sclerosis and Related Disorders. p. 7. ISSN 2211-0348

(2023) Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trial. Journal of Neurology Neurosurgery and Psychiatry. pp. 1004-1011. ISSN 0022-3050

(2023) The Efficacy of Fingolimod and Interferons in Controlling Disability and Relapse Rate in Patients with Multiple Sclerosis: A Systematic Review and Meta-Analysis. International Journal of Preventive Medicine. p. 10. ISSN 2008-7802

(2023) Emotional competencies in multiple sclerosis. Multiple Sclerosis and Related Disorders. p. 6. ISSN 2211-0348

(2023) External validation of a clinical prediction model in multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England). pp. 261-269. ISSN 1477-0970 (Electronic) 1352-4585 (Linking)

(2023) Fear of re-infection, relapse, and anxiety during COVID-19 pandemic in patients with multiple sclerosis: A multi-center study. Current Journal of Neurology. pp. 82-86. ISSN 2717-011X

(2023) Fingolimod-induced bladder lymphoma in a patient with multiple sclerosis. Clinical Case Reports. p. 4. ISSN 2050-0904

(2023) Late-onset multiple sclerosis in Iran: A report on demographic and disease characteristics. Multiple Sclerosis and Related Disorders. p. 5. ISSN 2211-0348

(2023) A Multi-Country Comparative Effectiveness Study of Dimethyl Fumarate and Non-Specific Immunosuppressants in a Real-World Setting: Evidence from MSBase. Multiple Sclerosis Journal. NP29-NP30. ISSN 1352-4585

(2023) Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccines: A systematic review. Revue Neurologique. pp. 265-281. ISSN 0035-3787

(2023) Multiple sclerosis and the incidence of venous thromboembolism: a systematic review and meta-analysis. Journal of Thrombosis and Thrombolysis. pp. 463-473. ISSN 0929-5305

(2023) Multiple sclerosis is associated with worse COVID-19 outcomes compared to the general population: A population-based study. Multiple Sclerosis and Related Disorders. p. 6. ISSN 2211-0348

(2023) Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease and COVID-19: A Systematic Review. Journal of Central Nervous System Disease. p. 15. ISSN 1179-5735

(2023) Neurosarcoidosis in an adult man with a family history of MS: A case report. Clinical Case Reports. p. 6. ISSN 2050-0904

(2023) Patterns of attention deficit in relapsing and progressive phenotypes of multiple sclerosis. Scientific Reports. p. 12. ISSN 2045-2322

(2023) Predictors of treatment switching in the Big Multiple Sclerosis Data Network. Frontiers in Neurology. p. 10. ISSN 1664-2295

(2023) Presentation of Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) in the Acute Phase of COVID-19 Infection. Journal of Clinical Neurology. pp. 195-197. ISSN 1738-6586

(2023) Prevalence of dysphagia in patients with multiple sclerosis: A systematic review and meta-analysis. Journal of Clinical Neuroscience. pp. 84-94. ISSN 0967-5868

(2023) Safety and Effectiveness of Cinnomer® on Disease Characteristics, Depression, and Quality of Life of Patients with Multiple Sclerosis: A Phase IV, Post-marketing, Prospective, Multicenter Study. Archives of Iranian Medicine. pp. 647-653. ISSN 1029-2977

(2023) Safety and efficacy of mesenchymal stem cell therapy in patients with multiple sclerosis during short- and long-term follow-up: a systematic review and meta-analysis. Multiple Sclerosis Journal. p. 1022. ISSN 1352-4585

(2023) Social support and anxiety correlation with resilience in patients with multiple sclerosis during COVID-19 pandemic. Current Journal of Neurology. pp. 217-220. ISSN 2717-011X

(2023) Sociodemographic and Neuroimaging Evaluation of Patients with Multiple Sclerosis and Radiologically Isolated Syndrome in Isfahan, Iran. Archives of Neuroscience. p. 8. ISSN 2322-3944

(2023) Thalamic asymmetry in Multiple Sclerosis. Multiple Sclerosis and Related Disorders. p. 7. ISSN 2211-0348

(2023) Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis. European Journal of Neurology. pp. 1014-1024. ISSN 1351-5101

(2023) Vascular comorbidities are associated with increased relapse rates in relapsing-remitting MS. Multiple Sclerosis Journal. pp. 84-86. ISSN 1352-4585

(2023) Working memory dysfunction differs between secondary progressive and relapsing multiple sclerosis: Effects of clinical phenotype, age, disease duration, and disability. Multiple Sclerosis and Related Disorders. p. 104411. ISSN 2211-0356 (Electronic) 2211-0348 (Linking)

(2023) Worldwide prevalence of neuromyelitis optica spectrum disorder (NMOSD) and neuromyelitis optica (NMO): a systematic review and meta-analysis. Neurological Sciences. pp. 1905-1915. ISSN 1590-1874

(2023) The association between multiple sclerosis and migraine: A meta-analysis. Multiple Sclerosis and Related Disorders. p. 12. ISSN 2211-0348

(2023) A mechanistic insight into sources of error of visual working memory in multiple sclerosis. Elife. p. 19. ISSN 2050-084X

(2022) Abrupt bilateral blindness as a rare post-acute demyelinating consequence of COVID-19. eNeurologicalSci. p. 100411. ISSN 2405-6502

(2022) Association of Disease-Modifying Therapies with COVID-19 Susceptibility and Severity in Patients with Multiple Sclerosis: A Systematic Review and Network Meta-Analysis. Multiple Sclerosis International. p. 13. ISSN 2090-2654

(2022) Association of Exposure to Particulate Matters and Multiple Sclerosis: A Systematic Review and Meta-Analysis. Neuroimmunomodulation. pp. 21-27. ISSN 1021-7401

(2022) Association of Latitude and Exposure to Ultraviolet B Radiation With Severity of Multiple Sclerosis An International Registry Study. NEUROLOGY. E2401-E2412. ISSN 0028-3878 1526-632X J9 - NEUROLOGY

(2022) Association of Latitude and Exposure to Ultraviolet B Radiation With Severity of Multiple Sclerosis: An International Registry Study. Neurology. e2401-e2412. ISSN 1526-632X (Electronic) 0028-3878 (Print) 0028-3878 (Linking)

(2022) Autoimmune hemolytic anemia after treatment with fingolimod in a patient with multiple sclerosis (MS): A case report and review of the literature. Autoimmunity Reviews. p. 2. ISSN 1568-9972

(2022) Bell's palsy after Sputnik V COVID-19 (Gam-COVID-Vac) vaccination. Clin Case Rep. e05468. ISSN 2050-0904 (Print) 2050-0904

(2022) COVID-19 infection and hospitalization rate in Iranian multiple sclerosis patients: What we know by May 2021. MULTIPLE SCLEROSIS AND RELATED DISORDERS. ISSN 2211-0348 2211-0356 J9 - MULT SCLER RELAT DIS

(2022) COVID-19 susceptibility and outcomes among patients with neuromyelitis optica spectrum disorder (NMOSD): A systematic review and meta-analysis. MULTIPLE SCLEROSIS AND RELATED DISORDERS. ISSN 2211-0348 2211-0356 J9 - MULT SCLER RELAT DIS

(2022) Characteristics of COVID-19 in patients with multiple sclerosis. MULTIPLE SCLEROSIS AND RELATED DISORDERS. ISSN 2211-0348 2211-0356 J9 - MULT SCLER RELAT DIS

(2022) Characteristics of COVID-19 in patients with multiple sclerosis. Multiple Sclerosis and Related Disorders. p. 103437. ISSN 2211-0356 (Electronic) 2211-0348 (Print) 2211-0348 (Linking)

(2022) Comparison of Disability in Patients with Multiple Sclerosis with and without Familial History. Journal of Isfahan Medical School. pp. 786-791. ISSN 10277595 (ISSN)

(2022) Comparison of follicular T helper cells, monocytes, and T cells priming between newly diagnosed and rituximab-treated MS patients and healthy controls. Res Pharm Sci. pp. 315-323. ISSN 1735-5362 (Print) 1735-5362

(2022) Confirmed disability progression as a marker of permanent disability in multiple sclerosis. EUROPEAN JOURNAL OF NEUROLOGY. pp. 2321-2334. ISSN 1351-5101 1468-1331 J9 - EUR J NEUROL

(2022) Confirmed disability progression as a marker of permanent disability in multiple sclerosis. European Journal of Neurology. pp. 2321-2334. ISSN 13515101 (ISSN)

(2022) Description of Multiple Sclerosis cohorts from the Middle East between 2009 and 2019. Multiple Sclerosis Journal. pp. 17-18. ISSN 1352-4585

(2022) Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis. NEUROLOGY. ISSN 0028-3878

(2022) Early non-disabling relapses are associated with a higher risk of disability accumulation in people with relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal. pp. 947-950. ISSN 1352-4585

(2022) The Effect of Interferon-Beta Therapy on T-Helper 17/miR-326 and T-Helper 1/miR-29b-3p Axis in Relapsing-Remitting Multiple Sclerosis Patients. Neuroimmunomodulation. pp. 177-185. ISSN 1021-7401

(2022) Effectiveness of BBIBP-CorV vaccine in preventing SARS-CoV2 infection and severe outcomes in patients with multiple sclerosis. Multiple Sclerosis Journal. p. 779. ISSN 1352-4585

(2022) Effects of Acceptance and Commitment Therapy (ACT) and Mindfulness-Based Stress Reduction (MBSR) on symptoms and emotional competencies in individuals with multiple sclerosis. Multiple Sclerosis and Related Disorders. p. 10. ISSN 2211-0348

(2022) Effects of Acceptance and Commitment Therapy (ACT) and Mindfulness-Based Stress Reduction (MBSR) on symptoms and emotional competencies in individuals with multiple sclerosis. Mult Scler Relat Disord. p. 104029. ISSN 2211-0348

(2022) The Effects of Garlic Extract on IL-17A IL-17F and IFNγ mRNA Expression in Peripheral Blood Mononuclear Cells of Multiple Sclerosis Patients. Journal of Isfahan Medical School. pp. 632-639. ISSN 10277595 (ISSN)

(2022) The Efficacy of Transdiagnostic Cognitive Behavioral Therapy on Migraine Headache: A Randomized Clinical Trial. Neurology. p. 2. ISSN 0028-3878

(2022) Ermin deficiency leads to compromised myelin, inflammatory milieu, and susceptibility to demyelinating insult. Brain pathology (Zurich, Switzerland). e13064. ISSN 1750-3639 (Electronic) 1015-6305 (Print) 1015-6305 (Linking)

(2022) Ermin deficiency leads to compromised myelin, inflammatory milieu, and susceptibility to demyelinating insult. BRAIN PATHOLOGY. ISSN 1015-6305 1750-3639 J9 - BRAIN PATHOL

(2022) Exposure to high geomagnetic disturbances and low ambient ultraviolet radiation are associated with an earlier age of multiple sclerosis onset in low latitude areas. Multiple Sclerosis Journal. pp. 987-988. ISSN 1352-4585

(2022) Fulminant neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccination: A need for reconsideration? Mult Scler Relat Disord. p. 104035. ISSN 2211-0348 (Print) 2211-0348

(2022) Hearing loss among patients with multiple sclerosis (PwMS): A systematic review and meta-analysis. MULTIPLE SCLEROSIS AND RELATED DISORDERS. ISSN 2211-0348 2211-0356 J9 - MULT SCLER RELAT DIS

(2022) Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis. BMC MEDICAL RESEARCH METHODOLOGY. ISSN 1471-2288 J9 - BMC MED RES METHODOL

(2022) Incidence of cancer in patients with multiple sclerosis (MS) who were treated with fingolimod: A systematic review and meta-analysis. MULTIPLE SCLEROSIS AND RELATED DISORDERS. ISSN 2211-0348 2211-0356 J9 - MULT SCLER RELAT DIS

(2022) Incidence, prevalence, and characteristics of heart failure among patients with multiple sclerosis: A systematic review and meta-analysis. MULTIPLE SCLEROSIS AND RELATED DISORDERS. ISSN 2211-0348 2211-0356 J9 - MULT SCLER RELAT DIS

(2022) Interdependency of NINJ2 gene expression and polymorphism with susceptibility and response to Interferon Beta in patients with Multiple Sclerosis. Int J Neurosci. pp. 1-9. ISSN 0020-7454

(2022) Is Myasthenia Gravis a Real Complication of the COVID-19 Vaccine? A Case Report-Based Systematic Review. Canadian Journal of Infectious Diseases & Medical Microbiology. p. 7. ISSN 1712-9532

(2022) Mizaj assessment in Multiple Sclerosis (MS) patients based on Persian Medicine. J Complement Integr Med. pp. 401-408. ISSN 1553-3840

(2022) Multiple Sclerosis Severity Score (MSSS) improves the accuracy of individualized prediction in MS. Mult Scler. p. 13524585221084577. ISSN 1352-4585

(2022) Olfactory dysfunction in patients with multiple sclerosis; A systematic review and meta-analysis. PLOS ONE. ISSN 1932-6203 J9 - PLOS ONE

(2022) Outcomes of Cerebral Venous Thrombosis due to Vaccine-Induced Immune Thrombotic Thrombocytopenia After the Acute Phase. Stroke. pp. 3206-3210. ISSN 0039-2499

(2022) Persistent cognitive impairment as a rare manifestation of mild COVID-19 infection – A case series. Romanian Journal of Neurology/ Revista Romana de Neurologie. pp. 78-82. ISSN 20696094 (ISSN)

(2022) Post COVID-19 infection neuromyelitis optica spectrum disorder (NMOSD): A case report-based systematic review. MULTIPLE SCLEROSIS AND RELATED DISORDERS. ISSN 2211-0348 2211-0356 J9 - MULT SCLER RELAT DIS

(2022) Predictors of Catching COVID-19 Infection during Pandemic Stage in Patients with Multiple Sclerosis (MS). International Journal of Preventive Medicine. p. 102. ISSN 2008-7802 (Print) 2008-8213 (Electronic) 2008-7802 (Linking)

(2022) Prevalence and Risk Factors of Dysphagia in Patients with Multiple Sclerosis. Dysphagia. pp. 21-27. ISSN 1432-0460 (Electronic) 0179-051X (Linking)

(2022) Prevalence and Risk Factors of Dysphagia in Patients with Multiple Sclerosis. Dysphagia. pp. 21-27. ISSN 0179-051x

(2022) Prevalence of multiple sclerosis (MS) in Iran: a systematic review and meta-analysis. Neurol Sci. pp. 233-241. ISSN 1590-1874

(2022) Prevalence of trigeminal neuralgia in multiple sclerosis: A systematic review and meta-analysis. MULTIPLE SCLEROSIS AND RELATED DISORDERS. ISSN 2211-0348 2211-0356 J9 - MULT SCLER RELAT DIS

(2022) Psychometric Properties of the Persian Version of the Multiple Sclerosis Work Difficulties Questionnaire (MSWDQ) Questionnaire. INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE. ISSN 2008-7802 2008-8213 J9 - INT J PREVENTIVE MED

(2022) Psychometric assessment of the Persian version of the patient determined disease steps scale in patients with multiple sclerosis and neuromyelitis optica spectrum disorder. Current Journal of Neurology. pp. 206-210. ISSN 2717-011X

(2022) Radiologically Isolated Syndrome: An Atypical Presentation of Balo's Concentric Sclerosis in a Patient with the Meniere's Disease. Neurol India. pp. 439-440. ISSN 0028-3886

(2022) Risk and severity of SARS-CoV-2 reinfection among patients with multiple sclerosis vs. the general population: a population-based study. Bmc Neurology. p. 10.

(2022) The Role of Cobalamin on Interleukin 10, Osteopontin, and Related <i>MicroRNAs</i> in Multiple Sclerosis. Iranian Journal of Allergy Asthma and Immunology. pp. 332-343. ISSN 1735-1502

(2022) The Role of Cobalamin on Interleukin 10, Osteopontin, and Related MicroRNAs in Multiple Sclerosis. IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY. pp. 332-343. ISSN 1735-1502 1735-5249 J9 - IRAN J ALLERGY ASTHM

(2022) Safety of Sinopharm vaccine for people with Multiple Sclerosis: Study of adverse reactions and disease activity. MULTIPLE SCLEROSIS AND RELATED DISORDERS. ISSN 2211-0348 2211-0356 J9 - MULT SCLER RELAT DIS

(2022) Sexual Dysfunction in Women with Neuromyelitis Optica Spectrum Disorders and Multiple Sclerosis. SEXUALITY AND DISABILITY. pp. 381-392. ISSN 0146-1044 1573-6717 J9 - SEX DISABIL

(2022) Sexual Dysfunction in Women with Neuromyelitis Optica Spectrum Disorders and Multiple Sclerosis. Sexuality and Disability. pp. 381-392. ISSN 01461044 (ISSN)

(2022) Short report: assessment of coping strategies in patients with neuromyelitis optica spectrum disorder (NMOSD) and multiple sclerosis. Psychol Health Med. pp. 1234-1244. ISSN 1354-8506

(2022) Sociodemographic and Illness-Related Indicators to Predict the Status of Neuromyelitis Optica Spectrum Disorder (NMOSD) Five Years after Disease Onset. JOURNAL OF CLINICAL MEDICINE. ISSN 2077-0383 J9 - J CLIN MED

(2022) Study of The Correlation between miR-106a, miR-125b, and miR-330 on Multiple Sclerosis Patients by Targeting TNFSF4 and SP1 in NF-eb/TNF-? Pathway: A Case-Control Study. Cell Journal. pp. 403-409. ISSN 2228-5806

(2022) Study of The Correlation between miR-106a, miR-125b, and miR-330 on Multiple Sclerosis Patients by Targeting TNFSF4 and SP1 in NF-кb/TNF-α Pathway: A Case-Control Study. Cell J. pp. 403-409. ISSN 2228-5806 (Print) 2228-5806

(2022) The efficacy of transdiagnostic cognitive behavioral therapy on migraine headache: a pilot, feasibility study. BMC NEUROLOGY. ISSN 1471-2377 J9 - BMC NEUROL

(2022) The prevalence of cancer in patients with multiple sclerosis (MS) who received rituximab: a systematic review and meta-analysis. Neurologia (Engl Ed). ISSN 2173-5808

(2022) The prevalence of sexual dysfunction (SD) and erectile dysfunction (ED) in men with multiple sclerosis (MS): a systematic review and meta-analysis. Neurologia (Engl Ed). ISSN 2173-5808

(2022) The risk of secondary progressive multiple sclerosis is geographically determined but modifiable. Multiple Sclerosis Journal. pp. 967-970. ISSN 1352-4585

(2021) Acute CNS demyelination in a subject with cerebellar ataxia following the first dose of COVID-19 mRNA vaccine; a case report. HUMAN VACCINES & IMMUNOTHERAPEUTICS. pp. 4099-4101. ISSN 2164-5515 2164-554X J9 - HUM VACC IMMUNOTHER

(2021) Acute Response of Stress System in Multiple Sclerosis. ARCHIVES OF NEUROSCIENCE. ISSN 2322-3944 2322-5769 J9 - ARCH NEUROSCI

(2021) Anti-myelin Oligodendrocyte Glycoprotein in Aquaporin-4 Negative Neuromyelitis Optica Spectrum Disorder. Caspian Journal of Neurological Sciences. pp. 10-16. ISSN 23834307 (ISSN)

(2021) Assessment of mental health, knowledge, and attitude of patients with multiple sclerosis and neuromyelitis optica spectrum disorder in response to 2019 novel coronavirus. Neurological Sciences. pp. 2891-2901. ISSN 1590-1874

(2021) Association of Exposure to Particulate Matters and Multiple Sclerosis: A Systematic Review and Meta-Analysis. Neuroimmunomodulation. pp. 1-7. ISSN 1021-7401

(2021) Comparable Efficacy and Safety of Teriflunomide versus Dimethyl Fumarate for the Treatment of Relapsing-Remitting Multiple Sclerosis. Neurol Res Int. p. 6679197. ISSN 2090-1852 (Print) 2090-1860

(2021) Comparison of susceptibility weighted imaging with conventional MRI sequences in multiple sclerosis plaque assessment: A cross-sectional study. JOURNAL OF RESEARCH IN MEDICAL SCIENCES. ISSN 1735-1995 1735-7136 J9 - J RES MED SCI

(2021) Disability outcomes of early cerebellar and brainstem symptoms in multiple sclerosis. Multiple Sclerosis Journal. pp. 755-766. ISSN 1352-4585

(2021) Effect of Disease-Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years. Neurology. E783-E797. ISSN 0028-3878

(2021) Effectiveness of bupropion on sexual dysfunction of women with multiple sclerosis: A clinical trial. Iranian Journal of Obstetrics, Gynecology and Infertility. pp. 59-70. ISSN 16802993 (ISSN)

(2021) Efficacy and safety of rituximab in treating patients with Neuromyelitis optica spectrum disorder (NMOSD): A systematic review and meta-analysis. Autoimmunity Reviews. ISSN 1568-9972

(2021) Evaluation of Month of Birth in Neuromyelitis Optica Spectrum Disorders (NMSOD) and Multiple Sclerosis (MS). Multiple Sclerosis International. ISSN 2090-2654

(2021) Expression and clinical significance of IL7R, NFATc2, and RNF213 in familial and sporadic multiple sclerosis. SCIENTIFIC REPORTS. ISSN 2045-2322 J9 - SCI REP-UK

(2021) Fear of relapse, social support, and psychological well-being (depression, anxiety, and stress level) of patients with multiple sclerosis (MS) during the COVID-19 pandemic stage. Neurological Sciences. pp. 2615-2618. ISSN 1590-1874

(2021) Gene expression profiles of YAP1, TAZ, CRB3, and VDR in familial and sporadic multiple sclerosis among an Iranian population. Scientific Reports. ISSN 2045-2322

(2021) High Prevalence of MMP9 1562C/T Gene Polymorphism in an Iranian Population of Neuromyelitis Optica, A Pilot Study. Gene Reports.

(2021) Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression. Comput Methods Programs Biomed. p. 106180. ISSN 0169-2607

(2021) Managing anxiety among multiple sclerosis patients during COVID-19 pandemic. JOURNAL OF RESEARCH IN MEDICAL SCIENCES. ISSN 1735-1995 1735-7136 J9 - J RES MED SCI

(2021) Modulation of Th17 Proliferation and IL-17A Gene Expression by Acetylated Form of Apigenin in Patients with Multiple Sclerosis. Immunological Investigations. pp. 216-229. ISSN 0882-0139

(2021) Paraparesis due to aortic thromboembolism as a rare complication of COVID-19 infection. JOURNAL OF VASCULAR SURGERY. p. 1047. ISSN 0741-5214 J9 - J VASC SURG

(2021) Pregnancy outcome in patients with neuromyelitis optica spectrum disorder treated with rituximab: A case-series study. CASPIAN JOURNAL OF INTERNAL MEDICINE. S491-S494. ISSN 2008-6164 2008-6172 J9 - CASP J INTERN MED

(2021) Prevalence of seizure/epilepsy in patients with multiple sclerosis: A systematic review and meta-analysis. International Journal of Preventive Medicine. ISSN 2008-7802

(2021) Rituximab and glatiramer acetate in secondary progressive multiple sclerosis: A randomized clinical trial. Acta Neurologica Scandinavica. pp. 178-187. ISSN 0001-6314

(2021) Safety and efficacy of fingolimod in Iranian patients with relapsing-remitting multiple sclerosis: An open-label study. Caspian J Intern Med. pp. 263-274. ISSN 2008-6164 (Print) 2008-6164

(2021) The Serum Level of Midkine in Patients With Multiple Sclerosis and Neuromyelitis Optica. Basic and Clinical Neuroscience. pp. 199-204. ISSN 2008-126X

(2021) Utilization of Multiple Sclerosis Therapies in the Middle East Over a Decade: 2009-2018. CNS Drugs. ISSN 1172-7047

(2021) Vitamin D level in iranian patients with neuromyelitis optica. Journal of Isfahan Medical School. pp. 370-375. ISSN 10277595 (ISSN)

(2021) YY Safety and efficacy of fingolimod in Iranian patients with relapsing-remitting multiple sclerosis: An open-label study. Caspian Journal of Internal Medicine. pp. 263-274. ISSN 2008-6164

(2021) The effect of emotional freedom technique on fatigue among women with multiple sclerosis: A randomized controlled trial. IRANIAN JOURNAL OF NURSING AND MIDWIFERY RESEARCH. pp. 531-536. ISSN 1735-9066 2228-5504 J9 - IRAN J NURS MIDWIFE

(2021) The prevalence of Myocardial Infarction among Multiple Sclerosis Patients: a Systematic Review and Meta-analysis. MULTIPLE SCLEROSIS AND RELATED DISORDERS. ISSN 2211-0348 2211-0356 J9 - MULT SCLER RELAT DIS

(2020) Pre-pregnancy, obstetric and delivery status in women with neuromyelitis optica spectrum disorder. Multiple Sclerosis and Related Disorders. ISSN 2211-0348

(2019) MicroRNA-29b variants and MxA expression change during interferon beta therapy in patients with relapsing-remitting multiple sclerosis. Multiple Sclerosis and Related Disorders. pp. 241-245. ISSN 2211-0348

(2016) Association of Serum Bilirubin Levels With Relapsing Remitting Multiple Sclerosis. Multiple Sclerosis Journal. p. 413. ISSN 1352-4585

(2016) Clinical significance of neutralizing antibodies to interferon beta in patients with Multiple Sclerosis. Journal of Immunology. ISSN 0022-1767

(2016) Co-occurrence of multiple sclerosis and Parkinson disease. Advanced biomedical research. p. 75. ISSN 2277-9175 (Print) 2277-9175 (Linking)

(2016) Consanguinity and multiple sclerosis susceptibility: A case control study. Multiple Sclerosis and Related Disorders. pp. 179-180. ISSN 2211-0348

(2016) Early disease modifying treatment delays disability accumulation in patients with pediatric onset clinically isolated syndrome suggestive of multiple sclerosis. Multiple Sclerosis Journal. pp. 62-63. ISSN 1352-4585

(2016) Effect of Disease Duration on Personality Type in Multiple Sclerosis Patients and Healthy Individual. Multiple Sclerosis Journal. p. 410. ISSN 1352-4585

(2016) Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis. Journal of Neurology Neurosurgery and Psychiatry. pp. 1343-1349. ISSN 0022-3050

(2016) Individual response to disease modifying therapies: a global observational cohort study. Multiple Sclerosis Journal. pp. 358-360. ISSN 1352-4585

(2016) Ischemic Strokes in a Young Woman With Manifestations of Multiple Sclerosis: Can Ischemic Stroke Mimic Multiple Sclerosis?. Multiple Sclerosis Journal. p. 443. ISSN 1352-4585

(2016) Long-term disability trajectories in primary progressivs MS patients - a latent class growth analysis. Multiple Sclerosis Journal. pp. 44-46. ISSN 1352-4585

(2016) Mental toughness, sleep disturbances, and physical activity in patients with multiple sclerosis compared to healthy adolescents and young adults. Neuropsychiatric Disease and Treatment. pp. 1571-1579. ISSN 1178-2021

(2016) Relation between Dietary Intakes of Antioxidants and Igg-NMO Titration in Patients with Neuromyelitisoptica. Multiple Sclerosis Journal. pp. 425-426. ISSN 1352-4585

(2016) Relationship between dietary intakes of antioxidant with EDSS and fatigue scale in MS. Multiple Sclerosis Journal. p. 749. ISSN 1352-4585

(2016) Serum Levels of Vitamin D and Igg-NMO Titration in Patients with Neuromyelitisoptica (NMO & NMOSD); Is There Any Correlation?. Multiple Sclerosis Journal. pp. 428-429. ISSN 1352-4585

(2016) Vasomotor reactivity comparison in multiple sclerosis patients with white matter lesions and nonmultiple sclerosis subjects with white matter lesions in brain magnetic resonance imaging. Advanced biomedical research. p. 23. ISSN 2277-9175 (Print) 2277-9175 (Linking)

(2016) The comparative assessment of vitamin D supplement on glycemic indices in autoimmune diseases. Biointerface Research in Applied Chemistry. pp. 1627-1630. ISSN 2069-5837

(2016) A comparison of the effects of reflexology and relaxation on pain in women with multiple sclerosis. Journal of Complementary and Integrative Medicine. pp. 65-71. ISSN 15533840 (ISSN)

(2016) The effect of electronic package on satisfaction in multiple sclerosis patients. Advanced biomedical research. p. 89. ISSN 2277-9175 (Print) 2277-9175 (Linking)

(2016) The environmental risk factors in multiple sclerosis susceptibility: A case-control study. Advanced biomedical research. p. 98. ISSN 2277-9175 (Print) 2277-9175 (Linking)

(2015) BREMSO: a simple score to predict early the natural course of multiple sclerosis. European Journal of Neurology. pp. 981-989. ISSN 1351-5101

(2015) Clinical utility of residual latency in ulnar neuropathy at elbow: Is there any correlation? Advanced biomedical research. p. 21. ISSN 2277-9175 (Print) 2277-9175 (Linking)

(2015) Comparing Urinary Symptoms in MS Patients versus Devic Patients. Multiple Sclerosis Journal. p. 814. ISSN 1352-4585

(2015) Comparing the effects of memantine and sodium valproate in prevention of chronic and episodic migraine. Journal of Isfahan Medical School. ISSN 10277595 (ISSN)

(2015) Comparing the effects of reflexology and relaxation on fatigue in women with multiple sclerosis. Iranian journal of nursing and midwifery research. pp. 200-4. ISSN 1735-9066 (Print) 1735-9066 (Linking)

(2015) Comparison of emotional and non-emotional word repetitions in patients with aphasia. Advanced biomedical research. p. 164. ISSN 2277-9175 (Print) 2277-9175 (Linking)

(2015) Cytokine Gene Expression in Newly Diagnosed Multiple Sclerosis Patients. Iranian Journal of Allergy Asthma and Immunology. pp. 208-216. ISSN 1735-1502

(2015) Cytokines gene expression in newly diagnosed multiple sclerosis patients. Iranian journal of allergy, asthma, and immunology. pp. 208-16. ISSN 1735-1502 (Print) 1735-1502 (Linking)

(2015) Depression and cognitive performances in patients with multiple sclerosis. Journal of Isfahan Medical School. pp. 1-11. ISSN 10277595 (ISSN)

(2015) The Effect of Plasma Exchange on the Expression of FOXP3 and RORC2 in Relapsed Multiple Sclerosis Patients. Iranian Journal of Immunology. pp. 311-318. ISSN 1735-1383

(2015) Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS. Plos One. ISSN 1932-6203

(2015) Mesenchymal Stem Cell Therapy in Multiple Sclerosis: An Updated Review of The Current Clinical Trials. Multiple Sclerosis Journal. p. 822. ISSN 1352-4585

(2015) Preliminary study on patients located at the Kashani/Isfahan Hospital with multiple sclerosis between the years 2011 and 2013. Advanced biomedical research. p. 165. ISSN 2277-9175 (Print) 2277-9175 (Linking)

(2015) Psychological well-being in people with multiple sclerosis in an Iranian population. Journal of Research in Medical Sciences. pp. 535-539. ISSN 1735-1995

(2015) Transocular Doppler and optic nerve sheath diameter monitoring to detect intracranial hypertension. Advanced biomedical research. p. 231. ISSN 2277-9175 (Print) 2277-9175 (Linking)

(2015) Yoga intervention on blood NO in female migraineurs. Advanced biomedical research. p. 259. ISSN 2277-9175 (Print) 2277-9175 (Linking)